Takatsuki, Japan

Yoshitaka Konishi

This inventor holds 16 USPTO granted patents, plus 1 CIPO patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 1977-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshitaka Konishi. Retrieved from https://idiyas.com/inventor/yoshitaka-konishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 174(Granted Patents)


Location History:

  • Takarazuka, JA (1977)
  • Takatsuki, JP (1979 - 1984)
  • Mishima, JP (1995)
  • Osaka, JP (1992 - 2000)

Company Filing History:


Years Active: 1977-2000

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovations of Yoshitaka Konishi

Introduction

Yoshitaka Konishi is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of heterocyclic compounds, holding a total of 16 patents. His work has been instrumental in advancing chemical research and applications.

Latest Patents

Among his latest patents are innovative heterocyclic compounds. One patent describes compounds of the formula wherein Y is a bond or alkylene. Another patent focuses on heterocyclic compounds with a formula that includes a hetero ring containing a nitrogen atom, with n ranging from 0 to 2 and Y being a bond or alkylene.

Career Highlights

Yoshitaka Konishi is currently employed at Ono Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His expertise in heterocyclic chemistry has led to numerous advancements in drug development.

Collaborations

He has collaborated with notable colleagues, including Masaki Hayashi and Sung J Lee, to further enhance the scope of their research and innovations.

Conclusion

Yoshitaka Konishi's contributions to the field of heterocyclic compounds exemplify his dedication to innovation and research. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…